BreakthroughT1D
Highly Engaged Employees
Non-Profit & Charitable Organizations · New York, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
200 Vesey St Fl 28, New York City, New Y...Phone Number
(800) 533-2873Website
www.breakthrought1d.orgRevenue
$223.8 MillionIndustry
About BreakthroughT1D
BreakthroughT1D Org Chart
Is BreakthroughT1D your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once BreakthroughT1D has new funding data
Congratulate Masked Content for being promoted to Masked Content at BreakthroughT1D
Earning: See what the market has to say on BreakthroughT1D recently announced quarterly report
Check if BreakthroughT1D has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when BreakthroughT1D launches new products
BreakthroughT1D, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BreakthroughT1D is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BreakthroughT1D had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at BreakthroughT1D
Find 2 more new buyers
Company Profile Activity
Activity Insights
BreakthroughT1D is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
BreakthroughT1D is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about BreakthroughT1D.
BreakthroughT1D Tech Stack
A closer look at the technologies used by BreakthroughT1D
Most Recent Scoops
BreakthroughT1D News & Media
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1DBreakthrough T1D and Sub-Zero Group Foundation Announce National Partnership to Support Type 1 Diabetes Research
NEW YORK and MADISON, Wis., June 2, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes research and advocacy organization, and the Sub-Zero Group Foundation, the philanthropic arm of Sub-Zero Group, manufacturer of Sub-Zero, Wolf, and Cove luxury...Breakthrough T1D Southern Ohio Chapter Hosts 42nd Annual Cincinnatian of the Year Gala, Raising Over $1 Million
NFL Cincinnati Bengals Offensive Tackle Orlando Brown, Jr. Honored as Breakthrough T1D's Cincinnatian of the Year The Super Bowl Champion Donated $100,000 to Breakthrough T1D in Honor of Saturday's Recognition CINCINNATI, May 12, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the...Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
NEW YORK, April 22, 2026 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision by the U.S. Food and Drug Administration (FDA) to approve Sanofi's Tzield (teplizumab-mzwv) for use in children...
Top Non-Profit & Charitable Organizations Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding BreakthroughT1D
As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate an... Read More